首页> 外国专利> A Noble Fusion Protein-based Nanoparticles and Uses Thereof

A Noble Fusion Protein-based Nanoparticles and Uses Thereof

机译:基于惰性融合蛋白的纳米粒子及其用途

摘要

The present invention relates to a novel mussel adhesion protein-based nanoparticles and uses thereof, and more specifically, a functional peptide fused to a mussel adhesion protein, a fusion protein for gene or drug delivery; A method of producing a fusion protein-based nanoparticle for gene or drug delivery based on the fusion protein; Gene or drug delivery fusion protein-based nanoparticles produced by the above method; And it provides a CRISPR / CAS9 gene editing system using the nanoparticles. The nanoparticles for gene or drug delivery based on the fusion protein according to the present invention have excellent biocompatibility because the functional peptide for gene delivery is fused to the mussel adhesive protein, and since it effectively penetrates into the target cell, CRISPR/CAS9 gene editing As a system as well as a biomaterial-based gene-editing carrier and a drug carrier that carries and delivers a target drug, it can be used for the treatment and research of various diseases.
机译:本发明涉及一种基于贻贝粘合蛋白的纳米颗粒及其用途,更具体地,融合到贻贝粘附蛋白的功能肽,融合蛋白为基因或药物递送;一种基于融合蛋白的基因或药物递送制备融合蛋白的纳米粒子的方法;基因或药物递送融合蛋白的基于基于方法的纳米颗粒通过上述方法制备;它提供了使用纳米颗粒的CRISPR / CAS9基因编辑系统。基于本发明的融合蛋白的基因或药物递送的纳米颗粒具有优异的生物相容性,因为基因递送的功能肽融合到贻贝粘合剂蛋白中,并且由于它有效地渗透到靶细胞中,CRISPR / CAS9基因编辑作为一种系统以及基于生物材料的基因编辑载体和携带并提供目标药物的药物载体,它可用于治疗和研究各种疾病。

著录项

  • 公开/公告号KR102253359B1

    专利类型

  • 公开/公告日2021-05-18

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR1020190036045

  • 发明设计人 차형준;양장우;정연수;조윤기;

    申请日2019-03-28

  • 分类号C07K14/435;C12N15/10;C12N15/11;C12N15/90;C12N9/22;B82Y5;

  • 国家 KR

  • 入库时间 2022-08-24 18:57:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号